Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 468

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial

Lu, Debin, Chen, Bing, Liang, Ziwen, Deng, Wuquan, Jiang, Youzhao, Li, Shufa, Xu, Jing, Wu, Qinan, Zhang, Zhonghui, Xie, Bing, Chen, Sihao·2011·Diabetes Research and Clinical Practice
DOI 10.1016/j.diabres.2010.12.010
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2010.12.010

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 35

  1. Hauber, 2006, The market in diabetes, Diabetologia, 49, 247, 10.1007/s00125-005-0108-0 · DOI
  2. Newton, 1999, The use of automated data to identify complications and comorbidities of diabetes: a validation study, J Clin Epidemiol, 52, 199, 10.1016/S0895-4356(98)00161-9 · DOI
  3. Adler, 1999, Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers, Diabetes Care, 22, 1029, 10.2337/diacare.22.7.1029 · DOI · Paper page
  4. Johannesson, 2009, Incidence of lower-limb amputation in the diabetic and nondiabetic general population a 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations, Diabetes Care, 32, 275, 10.2337/dc08-1639 · DOI · Paper page
  5. Jude, 2001, Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome, Diabetes Care, 24, 1433, 10.2337/diacare.24.8.1433 · DOI · Paper page
  6. Graziani, 2007, Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity, Eur J Vasc Endovas Surg, 33, 453, 10.1016/j.ejvs.2006.11.022 · DOI · Paper page
  7. O’Loughlin, 2010, Basic concepts to novel therapies: a review of the diabetic foot, Int J Low Extrem Wounds, 9, 90, 10.1177/1534734610371600 · DOI
  8. Kamihata, 2001, Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines, Circulation, 104, 1046, 10.1161/hc3501.093817 · DOI · Paper page
  9. Leblond, 2009, Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction, Stem Cells Cloning: Adv Appl, 2, 11, 10.2147/SCCAA.S6210 · doi:10.2147/sccaa.s6210
  10. Iwase, 2005, Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia, Cardiovasc Res, 66, 543, 10.1016/j.cardiores.2005.02.006 · DOI · Paper page
  11. Tang, 2006, Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion, Eur J Cardio-Thoracic Surg, 30, 353, 10.1016/j.ejcts.2006.02.070 · DOI · Paper page
  12. Honma, 2006, Intravenous infusion of immortalized human mesenchymal stm cells protects against injury in a cerebral ischemia model in adult rat, Exp Neurol, 199, 56, 10.1016/j.expneurol.2005.05.004 · DOI · Paper page
  13. Al-Khaldi, 2003, Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model, Ann Thorac Surg, 75, 204, 10.1016/S0003-4975(02)04291-1 · DOI · Paper page
  14. Silva, 2005, Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model, Circulation, 111, 150, 10.1161/01.CIR.0000151812.86142.45 · DOI · Paper page
  15. Kinnaird, 2004, Local delivery of marrow derived stromal cells augments collateral perfusion through paracrine mechanisms, Circulation, 109, 1543, 10.1161/01.CIR.0000124062.31102.57 · DOI · Paper page
  16. Shichinohe, 2010, Bone marrow stromal cells and bone marrow-derived mononuclear cells: which are suitable as cell source of transplantation for mice infarct brain?, Neuropathology, 30, 113, 10.1111/j.1440-1789.2009.01050.x · DOI
  17. Armiñán, 2010, Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction, J Am Coll Cardiol, 55, 2244, 10.1016/j.jacc.2009.08.092 · DOI
  18. Shibata, 2008, Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats, Diabetes, 57, 3099, 10.2337/db08-0031 · DOI · Paper page
  19. Kwon, 2008, Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats, Int Wound J, 5, 453, 10.1111/j.1742-481X.2007.00408.x · DOI · Paper page
  20. Tamarat, 2004, Impairment in ischemia-induced neovascularization in diabetes bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment, Am J Pathol, 164, 457, 10.1016/S0002-9440(10)63136-7 · DOI · Paper page
  21. El-Ftesi, 2009, Aging and diabetes impair the neovascular potential of adipose-derived stromal cells, Plast Reconstr Surg, 123, 475, 10.1097/PRS.0b013e3181954d08 · DOI
  22. Humpert, 2005, Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient, Exp Clin Endocrinol Diabetes, 113, 538, 10.1055/s-2005-872886 · doi:10.1055/s-2005-872886
  23. Stute, 2004, Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use, Exp Hematol, 32, 1212, 10.1016/j.exphem.2004.09.003 · DOI · Paper page
  24. Lasala, 2010, Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis, Angiology, 61, 551, 10.1177/0003319710364213 · DOI
  25. Tateishi-Yuyama, 2002, Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial, Lancet, 360, 427, 10.1016/S0140-6736(02)09670-8 · DOI · Paper page
  26. Drescher, 2006, Standard-protocol moving-table magnetic resonance angiography for planning of interventional procedures in patients with peripheral vascular occlusive disease, Clin Imaging, 30, 382, 10.1016/j.clinimag.2006.07.002 · doi:10.1016/j.clinimag.2006.07.002
  27. Lapeyre, 2005, Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography, Am J Roentgnol, 185, 1641, 10.2214/AJR.04.1111 · DOI
  28. Abdallah, 2008, Human mesenchymal stem cells: from basic biology to clinical applications, Gene Therapy, 15, 109, 10.1038/sj.gt.3303067 · DOI · Paper page
  29. Le Blanc, 2004, Treatment of severe acute graftversus-host disease with third party haplo identical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7 · DOI · Paper page
  30. Horwitz, 1999, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta, Nat Med, 5, 309, 10.1038/6529 · DOI · Paper page
  31. Prasad, 2010, Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study, Biol Blood Marrow Transplant
  32. Hare, 2009, A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction, J Am Coll Cardiol, 54, 2277, 10.1016/j.jacc.2009.06.055 · DOI · Paper page
  33. Duong Van Huyen, 2008, Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia, Mod Pathol, 21, 837, 10.1038/modpathol.2008.48 · DOI
  34. Wu, 2007, Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis, Stem Cells, 25, 2648, 10.1634/stemcells.2007-0226 · DOI · Paper page
  35. Fu, 2006, Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury, Wound Repair Regen, 14, 325, 10.1111/j.1743-6109.2006.00128.x · DOI · Paper page

Cited by

See all 468

Metadata

Authors
Lu, D., Chen, B., Liang, Z., Deng, W., Jiang, Y., Li, S., Xu, J., Wu, Q., Zhang, Z., Xie, B., & Chen, S.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2011-04
Volume
92
Issue
1
Pages
26-36
ISSN
0168-8227 (ISSN-L)
DOI
10.1016/j.diabres.2010.12.010
OpenAlex
W2126294104
Cited by
468
References
1
FWCI
13.43
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial. https://app.cochat.ai/papers/10.1016/j.diabres.2010.12.010
The paper
Lu, D., Chen, B., Liang, Z., Deng, W., Jiang, Y., Li, S., Xu, J., Wu, Q., Zhang, Z., Xie, B., & Chen, S. (2011). Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2010.12.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.